Clobex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7700081 GALDERMA LABS Foaming compositions for hair care
Jan, 2022

(1 year, 8 months ago)

Clobex is owned by Galderma Labs.

Clobex contains Clobetasol Propionate.

Clobex has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Clobex are:

  • US7700081

Clobex was authorised for market use on 05 February, 2004.

Clobex is available in shampoo;topical dosage forms.

Clobex can be used as topical treatment of scalp psoriasis.

The generics of Clobex are possible to be released after 03 January, 2022.

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Market Authorisation Date: 05 February, 2004

Treatment: Topical treatment of scalp psoriasis


How can I launch a generic of CLOBEX before it's drug patent expiration?
More Information on Dosage

CLOBEX family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic